Advanced therapeutic inhalation aerosols of a Nrf2 activator and RhoA/Rho kinase (ROCK) inhibitor for targeted pulmonary drug delivery in pulmonary hypertension: design, characterization, aerosolization, in vitro 2D/3D human lung cell cultures, and in vivo efficacy

Inhalable nanostructured microparticles of simvastatin, a Nrf2 activator and RhoA/Rho kinase (ROCK) inhibitor, were rationally designed for targeted pulmonary delivery as dry powder inhalers (DPIs) for the treatment of pulmonary hypertension (PH). Advanced particle engineering design technology was...

Descripción completa

Detalles Bibliográficos
Autores principales: Acosta, Maria F., Muralidharan, Priya, Grijalva, Carissa L., Abrahamson, Michael D., Hayes, Don, Fineman, Jeffrey R., Black, Stephen M., Mansour, Heidi M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7968029/
https://www.ncbi.nlm.nih.gov/pubmed/33719747
http://dx.doi.org/10.1177/1753466621998245

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7968029/
https://www.ncbi.nlm.nih.gov/pubmed/33719747
http://dx.doi.org/10.1177/1753466621998245

Ejemplares similares